AU2002222567A1 - Composition improved in solubility or oral absorbability - Google Patents

Composition improved in solubility or oral absorbability

Info

Publication number
AU2002222567A1
AU2002222567A1 AU2002222567A AU2002222567A AU2002222567A1 AU 2002222567 A1 AU2002222567 A1 AU 2002222567A1 AU 2002222567 A AU2002222567 A AU 2002222567A AU 2002222567 A AU2002222567 A AU 2002222567A AU 2002222567 A1 AU2002222567 A1 AU 2002222567A1
Authority
AU
Australia
Prior art keywords
solubility
oral absorbability
composition improved
absorbability
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002222567A
Other versions
AU2002222567B2 (en
Inventor
Yasuki Kato
Makoto Kigoshi
Hideki Morita
Jun Sugishita
Setsuko Yano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Co Ltd
Original Assignee
Kyowa Hakko Kirin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kirin Co Ltd filed Critical Kyowa Hakko Kirin Co Ltd
Priority claimed from PCT/JP2001/010488 external-priority patent/WO2002043704A1/en
Publication of AU2002222567A1 publication Critical patent/AU2002222567A1/en
Application granted granted Critical
Publication of AU2002222567B2 publication Critical patent/AU2002222567B2/en
Assigned to KYOWA HAKKO KIRIN CO., LTD. reassignment KYOWA HAKKO KIRIN CO., LTD. Alteration of Name(s) in Register under S187 Assignors: KYOWA HAKKO KOGYO CO., LTD.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002222567A 2000-12-01 2001-11-30 Composition improved in solubility or oral absorbability Ceased AU2002222567B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000-367040 2000-12-01
JP2000367040 2000-12-01
JP2001-127228 2001-04-25
JP2001127228 2001-04-25
PCT/JP2001/010488 WO2002043704A1 (en) 2000-12-01 2001-11-30 Composition improved in solubility or oral absorbability

Publications (2)

Publication Number Publication Date
AU2002222567A1 true AU2002222567A1 (en) 2002-08-15
AU2002222567B2 AU2002222567B2 (en) 2007-05-10

Family

ID=26605078

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2256702A Pending AU2256702A (en) 2000-12-01 2001-11-30 Composition improved in solubility or oral absorbability
AU2002222567A Ceased AU2002222567B2 (en) 2000-12-01 2001-11-30 Composition improved in solubility or oral absorbability

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2256702A Pending AU2256702A (en) 2000-12-01 2001-11-30 Composition improved in solubility or oral absorbability

Country Status (6)

Country Link
US (2) US7125565B2 (en)
EP (1) EP1364643A4 (en)
JP (2) JP4334869B2 (en)
AU (2) AU2256702A (en)
CA (1) CA2430288C (en)
WO (1) WO2002043704A1 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
JP4848558B2 (en) * 2001-05-08 2011-12-28 トーアエイヨー株式会社 Rapid-release tablets containing metformin hydrochloride
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JPWO2004035089A1 (en) * 2002-10-09 2006-02-09 協和醗酵工業株式会社 Treatment for hormone-dependent cancer
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
CZ298224B6 (en) * 2003-04-29 2007-07-25 Pliva Istrazivanje I Razvoj D.O.O. Pharmaceutical composition containing ribavirin as active substance and process for its preparation
US8530509B2 (en) 2003-06-20 2013-09-10 Siga Technologies, Inc. Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
JP4640821B2 (en) * 2003-07-24 2011-03-02 塩野義製薬株式会社 Dry syrup containing poorly water-soluble drugs
CA2536283A1 (en) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. Pharmaceutical preparations having an improved solubility
US20070122471A1 (en) * 2003-12-25 2007-05-31 Takeda Pharmaceutical Company Limited Method of improving suitability for granulation
KR20050104152A (en) 2004-04-28 2005-11-02 최승호 Enhancing systems for poorly absorptive drugs
RU2007106036A (en) 2004-08-31 2008-10-10 Пфайзер Продактс Инк. (Us) ANTIBODY TO CD40: DRUG AND METHODS
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
CA2584957C (en) 2004-10-21 2015-08-25 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
JP4754211B2 (en) * 2004-12-28 2011-08-24 ライオン株式会社 Granular pharmaceutical composition and method for producing the same
JP4997767B2 (en) * 2005-01-07 2012-08-08 大正製薬株式会社 Ubidecarenone-containing composition
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US20060280787A1 (en) * 2005-06-14 2006-12-14 Baxter International Inc. Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
JP2008230967A (en) * 2005-06-23 2008-10-02 Kowa Co Pharmaceutical composition
JP2007031377A (en) * 2005-07-28 2007-02-08 Nichi-Iko Pharmaceutical Co Ltd Glimepiride-containing drug excellent in usability
US20070026072A1 (en) * 2005-07-28 2007-02-01 Stephen Olsen Benzoquinones of enhanced bioavailability
MY151003A (en) 2005-09-12 2014-03-31 Actelion Pharmaceuticals Ltd Stable pharmaceutical composition comprising a pyrimidine-sulfamide
KR100754953B1 (en) 2005-09-14 2007-09-04 주식회사 대웅 A solublized material comprising ubidecarenone, aqueous solution and process for preparation thereof
AU2006325984A1 (en) 2005-12-14 2007-06-21 Kyowa Hakko Kirin Co., Ltd. Easily absorbed oral preparation containing xanthine derivative
JP2007314529A (en) * 2006-04-28 2007-12-06 Lion Corp Granulated particle, tablet and method for producing granulated particle
WO2008119659A2 (en) * 2007-03-29 2008-10-09 F. Hoffmann-La Roche Ag Pharmaceutical composition and process
CA2866037C (en) * 2007-04-23 2017-05-16 Siga Technologies, Inc. Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
US8110608B2 (en) * 2008-06-05 2012-02-07 Ecolab Usa Inc. Solid form sodium lauryl sulfate (SLS) pesticide composition
US20100120906A1 (en) * 2008-07-18 2010-05-13 Valeant Pharmaceuticals International Modified release formulation and methods of use
PT2391355T (en) 2009-05-19 2017-02-21 Celgene Corp Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
WO2011063268A2 (en) 2009-11-19 2011-05-26 Biogen Idec Ma Inc Novel synthetic methods
WO2011067667A2 (en) 2009-12-02 2011-06-09 Eurand Pharmaceuticals Limited Fexofenadine microcapsules and compositions containing them
CA3030671A1 (en) 2010-03-23 2011-09-29 Shanthakumar R. Tyavanagimatt Polymorphic forms of st-246 and methods of preparation
TWI526441B (en) * 2010-08-20 2016-03-21 中外製藥股份有限公司 Composition comprising tetracyclic compounds
US8968757B2 (en) 2010-10-12 2015-03-03 Ecolab Usa Inc. Highly wettable, water dispersible, granules including two pesticides
JP6031756B2 (en) * 2010-12-24 2016-11-24 ライオン株式会社 Granular pharmaceutical preparation and production method
BR112013027219A2 (en) * 2011-04-26 2016-12-27 Innopharmax Inc entacapone composition, process for preparing the entacapone composition, pharmaceutical composition, and use of the entacapone composition
KR101890649B1 (en) * 2013-07-30 2018-09-28 라이온 가부시키가이샤 Tablet
AU2015215638A1 (en) * 2014-02-04 2016-08-18 Argenta Innovation Limited Ectoparasite formulation
CA2946518C (en) 2014-04-25 2022-07-26 Chugai Seiyaku Kabushiki Kaisha Preparation containing tetracyclic compound at high dose
CN106458967A (en) 2014-04-25 2017-02-22 中外制药株式会社 Novel crystal of tetracyclic compound
TWI803187B (en) 2014-08-08 2023-05-21 日商中外製藥股份有限公司 Solid dispersion containing amorphous body of tetracyclic compound and preparation
WO2016074800A1 (en) * 2014-11-14 2016-05-19 Asoltech S.R.L. Composition based on coq10
EP3165218A1 (en) * 2015-11-06 2017-05-10 INDENA S.p.A. Water dispersible granulates containing oxidized or reduced forms of coenzyme q10
JP7312198B2 (en) * 2018-02-07 2023-07-20 スマヴァ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Pharmaceutical formulations, methods for producing pharmaceutical formulations, and pharmaceuticals containing the same
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS563326B2 (en) 1972-09-11 1981-01-24
JPS56110612A (en) 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Readily disintegrable and absorbable compression molded article of slightly soluble drug
DE3419131A1 (en) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen DIHYDROPYRIDINE COMBINATION PREPARATIONS AND METHOD FOR THE PRODUCTION THEREOF
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers
US5266581A (en) 1984-07-04 1993-11-30 Bayer Aktiengesellschaft Solid composition containing dihydropyridine, PVP and PVPP
DE3424553A1 (en) 1984-07-04 1986-01-09 Bayer Ag, 5090 Leverkusen SOLID DRUG PREPARATIONS WITH DIHYDROPYRIDINE AND METHOD FOR THE PRODUCTION THEREOF
DE3433239A1 (en) 1984-09-11 1986-03-20 Bayer Ag, 5090 Leverkusen SOLID PHARMACEUTICAL PREPARATION CONTAINING NITRENDIPINE AND METHOD FOR THE PRODUCTION THEREOF
US4684636A (en) 1985-06-24 1987-08-04 Sterling Drug Inc. Antiandrogenic sulfonylsteroidopyrazoles and processes for preparation method of use and compositions thereof
JPH04275216A (en) * 1991-03-04 1992-09-30 Eisai Co Ltd Freeze-dried composition containing fat-soluble medicine
JP3390477B2 (en) * 1993-01-25 2003-03-24 生化学工業株式会社 Pharmaceutical composition and method for producing the same
US5976570A (en) 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
ATE240734T1 (en) 1995-07-26 2003-06-15 Kyowa Hakko Kogyo Kk PREPARATION OF XANTHINDERIVATES AS A SOLID DISPERSION
AR004014A1 (en) * 1995-10-13 1998-09-30 Meiji Seika Kaisha AN ANTIBACTERIAL COMPOSITION OF CEFDITOREN PIVOXILO FOR ORAL ADMINISTRATION AND METHOD TO OBTAIN SUCH COMPOSITION
US5676570A (en) * 1996-03-15 1997-10-14 Minnesota Mining And Manufacturing Company "F" port interface connector
DE19637082A1 (en) 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Rapidly disintegrating pellets
JPH10130142A (en) 1996-10-31 1998-05-19 Zensei Yakuhin Kogyo Kk Sustained release type compressed preparation
FR2758459B1 (en) 1997-01-17 1999-05-07 Pharma Pass FENOFIBRATE PHARMACEUTICAL COMPOSITION HAVING HIGH BIODAVAILABILITY AND PROCESS FOR PREPARING THE SAME
EP0974366B1 (en) * 1997-03-28 2006-10-18 Eisai Co., Ltd. Oral pharmaceutical preparations decreased in bitterness by masking
US5880115A (en) 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6288050B1 (en) 1997-07-18 2001-09-11 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
WO2000004896A1 (en) * 1998-07-22 2000-02-03 Yamanouchi Pharmaceutical Co., Ltd. Solid preparation containing sparingly soluble nsaids
JP2000086509A (en) 1998-09-14 2000-03-28 Taisho Yakuhin Kogyo Kk Production of sofalcone-containing preparation
JP4394765B2 (en) * 1999-02-15 2010-01-06 Basfポゾリス株式会社 Cement additive
DK1300160T3 (en) 2000-05-24 2014-03-24 Otsuka Pharma Co Ltd Method for stabilizing a composition

Similar Documents

Publication Publication Date Title
AU2002222567A1 (en) Composition improved in solubility or oral absorbability
AU2256702A (en) Composition improved in solubility or oral absorbability
AU2001271055A1 (en) Pharmaceutical composition improved in peroral absorbability
AU7105501A (en) Pharmaceutical composition improved in peroral absorbability
IL152659A0 (en) Pharmaceutical composition
HK1075889A1 (en) Pharmaceutical composition
HUP0301042A3 (en) Pharmaceutical composition useful in contraception
HUP0204555A3 (en) Pharmaceutical composition
AU2001258801A1 (en) Gelling composition
AU2001283845A1 (en) Flavour composition
AU2002216059A1 (en) Oral bleaching composition
AU2002221115A1 (en) Medicinal compositions having improved absorbability
AU2001290239A1 (en) Medicinal composition
AU2001269175A1 (en) Diamino phenothiazine derivatives and composition comprising same
IL154238A0 (en) Pharmaceutical composition
IL154240A0 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
AU2001241098A1 (en) Composition
AU2001270235A1 (en) Oral compositions
AU4085201A (en) Pharmaceutical composition
AU2001275201A1 (en) Acne-treating composition
AU2001287852A1 (en) Composition
AU2001290669A1 (en) Oral compositions
AU2001267541A1 (en) Vaccine composition
AU2001287732A1 (en) Copolycarbonate-based composition
AU2001278487A1 (en) Oral composition